Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (201-210 of 483) with videos related to

Pageof 49
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 15, 2026
Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI StudyHalet Türkantoz, Christiane Dobbelstein, Richard Greil, et al.
Technology in Cancer Research & Treatment|May 20, 2024
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer PatientsThomas Parigger, Franz Josef Gassner, Stephan Drothler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2007
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study GroupRainer Porschen, Hendrik-Tobias Arkenau, Stephan Kubicka, et al.
BMC Cancer|December 24, 2015
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck CancerFlorian Huemer, Thomas Melchardt, Wolfgang Tränkenschuh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPIThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2017
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patientsGudrun Piringer, Michael Fridrik, Alfred Fridrik, et al.
Acta Oncologica (Stockholm, Sweden)|October 5, 2019
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancerAntroula Papakonstantinou, Elham Hedayati, Mats Hellström, et al.
Leukemia & Lymphoma|May 7, 2014
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeuticsThomas Melchardt, Lukas Weiss, Clemens Hufnagl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast CancerIvana Sestak, Martin Filipits, Richard Buus, et al.
Clinical Breast Cancer|June 30, 2009
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?Michael Gnant, Peter Dubsky, Florian Fitzal, et al.
Pageof 49

Showing results (201-210 of 483) with videos related to

Sort By:
Pageof 49
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 15, 2026
Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI StudyHalet Türkantoz, Christiane Dobbelstein, Richard Greil, et al.
Technology in Cancer Research & Treatment|May 20, 2024
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer PatientsThomas Parigger, Franz Josef Gassner, Stephan Drothler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2007
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study GroupRainer Porschen, Hendrik-Tobias Arkenau, Stephan Kubicka, et al.
BMC Cancer|December 24, 2015
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck CancerFlorian Huemer, Thomas Melchardt, Wolfgang Tränkenschuh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPIThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2017
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patientsGudrun Piringer, Michael Fridrik, Alfred Fridrik, et al.
Acta Oncologica (Stockholm, Sweden)|October 5, 2019
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancerAntroula Papakonstantinou, Elham Hedayati, Mats Hellström, et al.
Leukemia & Lymphoma|May 7, 2014
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeuticsThomas Melchardt, Lukas Weiss, Clemens Hufnagl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast CancerIvana Sestak, Martin Filipits, Richard Buus, et al.
Clinical Breast Cancer|June 30, 2009
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?Michael Gnant, Peter Dubsky, Florian Fitzal, et al.
Pageof 49